Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study Hina QayoomUmar MehrajManzoor Ahmad Mir Original Paper 23 July 2022 Article: 158
Synthesis and biological evaluation of thiosemicarbazone derivatives Murat DoğanÜmit M. KoçyiğitYakup Budak Original Paper 21 July 2022 Article: 157
STARD5 as a potential clinical target of hepatocellular carcinoma Qi LiuXiaoxiao DuWei Hong Original Paper 19 July 2022 Article: 156
Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma Pradeep KumarAmit Kumar SinghSunil Kumar Mishra Original Paper 19 July 2022 Article: 155
Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma Honglei GuoYangyang JiXin Huang Original Paper 19 July 2022 Article: 154
Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial Yuko KanbayashiKoichi SakaguchiTetsuya Taguchi Original Paper 19 July 2022 Article: 153
Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study Esraa S. AbdalkhalekLamia M. El WakeelNagwa A. Sabri Original Paper Open access 19 July 2022 Article: 152
The role of PIP5K1A in cancer development and progression Man YinYunfei Wang Review Article 19 July 2022 Article: 151
Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer Ahmad SalahuddinHeba GhanemMaged Wasfy Helmy Original Paper Open access 18 July 2022 Article: 150
Molecular perspective on targeted therapy in breast cancer: a review of current status Busra Demir CetinkayaCigir Biray Avci Review Article 14 July 2022 Article: 149
Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma Ting WangYunhong YaoYi Zhao Review Article 14 July 2022 Article: 148
A pharmacological exploration of targeted drug therapy in non-small cell lung cancer Ajay P. JayanK. R. AnanduV. N. Saiprabha Review Article 14 July 2022 Article: 147
Comprehensive transcriptomic and co-expression analysis of ABL1 gene and molecularly targeted drugs in hepatocellular carcinoma based on multi-database mining Feifei LanXinqia ChenXiao Zhu Original Paper 14 July 2022 Article: 146
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice Giandomenico RovielloMartina CatalanoLorenzo Antonuzzo Review Article 14 July 2022 Article: 145
GANT61/BI-847325 combination: a new hope in lung cancer treatment Abdel Halim M. El-KishkyNermine MoussaMedhat Haroun Original Paper Open access 14 July 2022 Article: 144
Unraveling the therapeutic potential of GANT61/Dactolisib combination as a novel prostate cancer modality Mohamed YoussefNermine MoussaMedhat Haroun Original Paper Open access 14 July 2022 Article: 143
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells Shane O’GradyJohn CrownMichael J. Duffy Original Paper Open access 14 July 2022 Article: 142
Bioinformatic analysis identifies epidermal development genes that contribute to melanoma progression Gastón BarberoMaría Victoria CastroPablo Lopez-Bergami Original Paper 14 July 2022 Article: 141
c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer Zimu WangYicong HuangYong Song Original Paper 14 July 2022 Article: 140
Epialleles and epiallelic heterogeneity in hematological malignancies Leonidas BenetatosAgapi BenetatouGeorgios Vartholomatos Review Article 14 July 2022 Article: 139
